Abstract:Objective To determine the accurate age-adjusted incidence of prostate small cell carcinoma (SCC), update the clinical and pathological characteristics, as well as survival data of prostate SCC from Surveillance, Epidemiology, and End Results (SEER) datasets. Methods A total of 260 patients with prostate SCC were selected from the SEER database of the National Cancer Institute between 2004 and 2015. Age-adjusted incidence (AAI) rates, the observed and relative survival rates were evaluated over time by the SEER*Stat Software version 8.3.5. Overall survival (OS) rates that stratified by summary stage and treatment effects were evaluated by Kaplan-Meier method. The significant differences were assessed in a log-rank test. Univariate and multivariate cox hazard regression analysis were performed to determine independent predictors of OS. Results The incidence of prostate SCC has increased over time. The average age of prostate SCC patients was 70.25 years. More than 90% of tumors were poorly differentiated or undifferentiated. The majority of prostate SCC (77.7%) was at stage IV. 49% of patients had lymph node metastases and 68% of patients presented distant metastases (Compared with 60.5% of patients with distant metastases between 1973-2003). Interestingly only 23.5% patients had high level PSA (>10 ng/mL). 58.8% of patients underwent chemotherapy, 25.4% of patients were treated by surgery, and 31.9% of patients were treated by radiotherapy. The observed survival rates of 1-year, 2-year, and 5-year were 42.1%, 22.1%, and 12.5%, respectively (Compared with 47.9%, 27.5%, and 14.3%, respectively, between 1973 and 2003). Chemotherapy prolonged the OS of patients with regional (distant) metastases from 3 months (2 months) to 12 months (9 months). Multivariate cox regression analysis showed age, race, and stage were independent prognostic factors for prostate SCC patients. Conclusion Prostate SCC is a highly malignant cancer and our analysis of recent data has shown its incidence is increasing. Incidence rate of metastatic prostate SCC has increased and the survival rates have worsened in recent years. However, chemotherapy shows some survival benefit for prostate SCC patients with regional and distant metastasis over other treatment methods. Further work is needed to understand the reason prognosis of this type prostate cancer is worsening.

Reduced Survival of Young Patients under 55 Years with Metastatic Prostate Cancer: a Population-Based Study

Disparities of Age-Based Cancer-Specific Survival Improvement with Various Clinicopathologic Characteristics for Kidney Cancer

Current trend of worsening prognosis of prostate small cell carcinoma: A population-based study

Prognosis of Prostate Cancer and Bone Metastasis Pattern of Patients: a SEER-based Study and a Local Hospital Based Study from China

Prognostic Significance of Young Age and Non-Bone Metastasis at Diagnosis in Patients with Metastatic Prostate Cancer: a SEER Population-Based Data Analysis

Sites of Synchronous Distant Metastases and Prognosis in Prostate Cancer Patients with Bone Metastases at Initial Diagnosis: a Population-Based Study of 16,643 Patients.

The survival outcomes of very young and elderly patients with high-risk prostate cancer after radical treatments: A population-matched study

The Prognostic Impact of Age in Different Molecular Subtypes of Breast Cancer: a Population-Based Study.

Reduced Cancer-Specific Survival of Low Prostate-Specific Antigen in High-Grade Prostate Cancer: A Population-Based Retrospective Cohort Study.

Survival Outcomes of Low Prostate-Specific Antigen Levels and T Stages in Patients with High-Grade Prostate Cancer: a Population-Matched Study.

Clinical features and treatment strategies for older prostate cancer patients with bone metastasis.

Prognosis of Men with High-Risk Prostate Cancer Stratified by Risk Factors: a Population-Based Retrospective Cohort Study.

The U Shape of Prostate-specific Antigen and Prostate Cancer-specific Mortality in High-grade Metastatic Prostate Adenocarcinoma

Metastasis patterns and prognosis of octogenarians with metastatic breast cancer: A large-cohort retrospective study

Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study

Metastasis patterns and prognosis in young breast cancer patients: A SEER database analysis

Impact of Age at Diagnosis on Prostate Cancer Treatment and Survival

Clinical features and prognostic factors for patients with bone metastases from prostate cancer.

Gleason score, surgical and distant metastasis are associated with cancer-specific survival and overall survival in middle aged high-risk prostate cancer: A population-based study

Survival Outcomes for Metastatic Prostate Cancer Patients Treated With Radical Prostatectomy or Radiation Therapy: A SEER-based Study

Clinical Outcome of Advanced and Metastatic Renal Cell Carcinoma Treated with Targeted Therapy: is There a Difference Between Young and Old Patients?